Cutler Group LP Vanda Pharmaceuticals Inc. Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$10.84 - $16.55 $67,750 - $103,437	-6,250 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$15.69 - $21.14 $98,062 - $132,125	6,250 New	6,250 $98,000
Q3 2018 Nov 07, 2018	SELL	$18.25 - $23.0 $1,825 - $2,300	-100 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$14.05 - $20.2 $18,265 - $26,260	-1,300 Reduced 92.86%	100 $1,000
Q3 2017 Oct 17, 2017	BUY	$15.4 - $18.85 $21,560 - $26,390	1,400	1,400 $25,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $264M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.